Tristel plc (FRA:R1V)

Market Cap	231.13M +14.3%
Revenue (ttm)	59.36M +10.0%
Net Income	9.27M +20.2%
EPS	0.20 +19.8%
Shares Out	n/a
PE Ratio	23.92
Forward PE	21.74
Dividend	0.18 (3.73%)
Ex-Dividend Date	Nov 26, 2026

Volume	98
Open	4.560
Previous Close	4.560
Day's Range	4.560 - 4.720
52-Week Range	3.940 - 5.500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 19, 2026

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 282
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: R1V

Financial Performance

In fiscal year 2026, Tristel's revenue was 51.12 million, an increase of 10.02% compared to the previous year's 46.46 million. Earnings were 7.98 million, an increase of 20.24%.

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error